The American journal of orthopedics
-
Shared decision-making provides patients a measure of autonomy in making choices for their health and their future. Patient-reported outcome measures (PROMs) use clinically sensitive and specific metrics to evaluate a patient's self-reported pain, functional ability, and mental state. We conducted a study to create an evidence-based clinical decision-making tool. ⋯ Preoperative Veterans RAND 12-Item Health Survey (VR-12) mental health component summary (MCS) scores predicted self-reported pain and function (Ps < .001) 1 year after surgery. In these models, preoperative VR-12 MCS score was the most predictive PROM for 1-year postoperative VAS pain score (ω2 = .023) and 1-year postoperative ASES Function score (ω2 = .029). Together, a patient's preoperative VAS pain score, ASES Function score, VR-12 MCS score, age, sex, and type of arthroplasty can provide significant predictive value that may aid in setting appropriate expectations for pain and function 1 year after surgery.
-
Simultaneous bilateral total knee arthroplasty (BTKA) is often performed to treat patients with disabling arthritis of both knees. Its use compared with staged procedures remains controversial. In a retrospective study, we compared 371 patients who had simultaneous BTKA with 67 patients who had staged (<6 months apart) BTKA. ⋯ Overall, there was no significant difference in complication rates between the 2 cohorts (P = .97). Mean transfusion rate was higher for the simultaneous BTKA group (P = .042). Study limitations included the retrospective design and the relatively small sample, given the low incidence of complications.
-
Comparative Study
Liposomal Bupivacaine vs Interscalene Nerve Block for Pain Control After Shoulder Arthroplasty: A Retrospective Cohort Analysis.
The aim of this study was to compare liposomal bupivacaine and interscalene nerve block (ISNB) for analgesia after shoulder arthroplasty. We compared 37 patients who received liposomal bupivacaine vs 21 who received ISNB after shoulder arthroplasty by length of hospital stay (LOS), opioid consumption, and postoperative pain. Pain was the same in both groups for time intervals of 1 hour and 8 to 14 hours postoperatively. ⋯ Mean LOS for liposomal bupivacaine patients was 46 ± 20 hours vs 57 ± 14 hours for ISNB patients (P = .012). Sixteen of 37 liposomal bupivacaine patients vs 2 of 21 ISNB patients were discharged on the first postoperative day (P = .010). Liposomal bupivacaine was associated with less pain, less opioid consumption, and shorter hospital stays after shoulder arthroplasty compared with ISNB.
-
Review Case Reports
Fat Embolism Syndrome With Cerebral Fat Embolism Associated With Long-Bone Fracture.
Fat embolism syndrome (FES) is a well-known sequela of long-bone fracture and fixation. FES most commonly affects the pulmonary system. Brain emboli may lead to a symptomatic cerebral fat embolism (CFE), which is devastating. ⋯ The diagnosis was stroke and resultant diffuse encephalopathy secondary to CFE. Within days of urgent management, the patient's cognitive and ophthalmologic deficits were substantially improved. Six months after surgery, cognitive and ophthalmologic recovery was excellent, and the fractures were healing with good functional recovery in the affected limb.
-
The opioid epidemic has become a national public health and safety problem affecting both adults and adolescents. There is little doubt that this epidemic is rooted in the need for pain control after surgery and that orthopedic surgeons have in part contributed to opioid overprescription. Indeed, opioid abuse, misuse, and diversion are associated with increased hospitalizations, emergency department visits, and associated health care costs. ⋯ As such, there is an urgent need to address the opioid epidemic. Toward that end, several professional and governmental organizations have recommended opioid-sparing pain management approaches for surgeries-approaches that target different pain pathways to achieve adequate pain control. Such multimodal analgesia approaches are expected to reduce the writing of postoperative opioid prescriptions and their related adverse effects.